Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $34.9M | $56.5M | $99.7M | $149M | $202M | $266M | $297M |
| Revenue growth | — | — | — | 61.9% | 76.3% | 49.1% | 36.0% | 31.8% | 11.6% |
| Gross profit | — | $0.00 | $26.9M | — | — | $89.8M | $138M | $182M | $197M |
| Gross margin | — | — | 77.1% | — | — | 60.4% | 68.1% | 68.5% | 66.3% |
| Operating income | -$11.7M | -$46.1M | -$98.9M | -$153M | -$44.4M | -$65.3M | -$49.2M | -$34.4M | -$32.7M |
| Operating margin | — | — | -283.3% | -270.7% | -44.6% | -44.0% | -24.4% | -12.9% | -11.0% |
| Net income | -$4.48M | -$46.9M | -$90.0M | -$163M | -$46.8M | -$74.4M | -$61.7M | -$50.4M | -$51.6M |
| Net margin | — | — | -257.8% | -288.3% | -47.0% | -50.1% | -30.5% | -18.9% | -17.4% |
| EPS (diluted) | -$0.27 | -$1.92 | -$3.19 | -$4.83 | -$0.94 | -$1.33 | -$1.08 | -$0.81 | -$0.80 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13.2M | -$25.7M | -$93.4M | -$57.9M | -$33.4M | -$84.9M | -$34.0M | -$18.0M | -$42.3M |
| Capital expenditures | $0.00 | $9.00K | $345K | $815K | $393K | $1.62M | $473K | $1.47M | $3.44M |
| Free cash flow | -$13.2M | -$25.7M | -$93.7M | -$58.7M | -$33.8M | -$86.5M | -$34.5M | -$19.5M | -$45.7M |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $0.00 | $93.2M | $110M | $103M | $146M | $53.9M | $62.8M | $87.0M | $53.8M |
| Total assets | $152M | $172M | $240M | $209M | $257M | $178M | $189M | $233M | $226M |
| Total liabilities | $228M | $87.5M | $161M | $282M | $176M | $159M | $210M | $227M | $249M |
| Long-term debt | — | $0.00 | $73.5M | — | $71.2M | $71.9M | $120M | $122M | $146M |
| Shareholders' equity | -$75.5M | $84.4M | $79.5M | -$73.0M | $81.9M | $18.5M | -$20.7M | $5.52M | -$23.1M |
| Retained earnings | -$75.5M | -$123M | -$213M | -$376M | -$423M | -$497M | -$559M | -$609M | -$661M |
| Shares (wtd avg diluted) | 16.5M | 27.3M | 33.6M | 33.7M | 49.8M | 56.1M | 56.9M | 62.0M | 64.5M |
Every figure is extracted from Evolus, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.